Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

SELL
$0.71 - $0.97 $4,157 - $5,680
-5,856 Reduced 36.33%
10,264 $9.38 Million
Q3 2023

Nov 07, 2023

BUY
$0.96 - $2.01 $15,475 - $32,401
16,120 New
16,120 $15.8 Million

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $779M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Fidelis Capital Partners, LLC Portfolio

Follow Fidelis Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fidelis Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fidelis Capital Partners, LLC with notifications on news.